Literature DB >> 7901313

Hapten-immune pulmonary interstitial fibrosis (HIPIF) in mice requires both CD4+ and CD8+ T lymphocytes.

H Hu1, J Stein-Streilein.   

Abstract

We present a description and analysis of a mouse model for pulmonary interstitial fibrosis that is induced by a specific immune response to a small reactive chemical group called trinitrophenyl. We describe the model, and then we examine the cellular mechanism for the induction of the fibrosis. The specific increase in hydroxyproline reached a peak by day 7 and persisted through day 28 in all animals that were sensitized to and challenged with the hapten. Distinct patterns of fibrosis that were seen histologically correlated with antigenic pretreatment and were dependent on T lymphocytes. We also report that the inflammatory and fibrotic responses could be adoptively transferred with immune lymphocytes but not with immune serum. In vivo administration of anti-CD4 and anti-CD8 monoclonal antibodies to sensitized mice prevented the development of immune-mediated lung inflammation and was effective in reducing hydroxyproline deposition. We conclude that (activated) T lymphocytes contribute to the pathogenesis of pulmonary fibrotic diseases. The possibility arises that haptens in the environment may promote sensitization of individuals via their skin or lungs and cell-mediated immune responses to haptenated antigens within the lung may promote pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901313     DOI: 10.1002/jlb.54.5.414

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent.

Authors:  P J Christensen; R E Goodman; L Pastoriza; B Moore; G B Toews
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis.

Authors:  J Zhang-Hoover; A Sutton; N van Rooijen; J Stein-Streilein
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

4.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

5.  Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease.

Authors:  R I Enelow; A Z Mohammed; M H Stoler; A N Liu; J S Young; Y H Lou; T J Braciale
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

Review 6.  An update on stem cell transplantation in autoimmune rheumatologic disorders.

Authors:  Sheryl Mascarenhas; Belinda Avalos; Stacy P Ardoin
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

7.  CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis.

Authors:  Zoe Daniil; Panagiota Kitsanta; George Kapotsis; Maria Mathioudaki; Androniki Kollintza; Marilena Karatza; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  Respir Res       Date:  2005-07-24

8.  Prognosis of nonspecific interstitial pneumonia correlates with perivascular CD4+ T lymphocyte infiltration of the lung.

Authors:  Ling Qin; WenZe Wang; HongRui Liu; Yi Xiao; MingWei Qin; WenJie Zheng; JuHong Shi
Journal:  BMC Pulm Med       Date:  2015-10-24       Impact factor: 3.317

Review 9.  The regulation of pulmonary immunity.

Authors:  M F Lipscomb; D E Bice; C R Lyons; M R Schuyler; D Wilkes
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.